Real-Life Experience Regarding Clinical Characteristics and Treatment Outcome in Non-Cutaneous Peripheral T-Cell Lymphomas: A Multicenter Study of the Turkish Hematology Research and Education Group (ThREG)


Creative Commons License

Kayikci O., MEHTAP Ö., Sari I., DEMİRKAN F., Beyan C., ÇETİN G., ...More

TURKISH JOURNAL OF HEMATOLOGY, vol.39, no.3, pp.170-177, 2022 (SCI-Expanded) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 39 Issue: 3
  • Publication Date: 2022
  • Doi Number: 10.4274/tjh.galenos.2022.2022.0052
  • Journal Name: TURKISH JOURNAL OF HEMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.170-177
  • Keywords: Lymphomas, Autologous stem cell transplantation, T-cell lymphomas, Non-Hodgkin lymphoma, HIGH-DOSE CHEMOTHERAPY, AMERICAN SOCIETY, UP-FRONT, TRANSPLANTATION, SURVIVAL, GUIDELINES, PROGNOSIS, DISEASE, COHORT
  • Kocaeli University Affiliated: Yes

Abstract

Objective: Peripheral T-cell lymphomas (PTCLs) are an uncommon and quite heterogeneous group of disorders, representing only 10%-15% of all non-Hodgkin lymphomas. Although both molecular and clinical studies have increased in recent years, we still have little knowledge regarding real-life practice with PTCLs. In this study, we aimed to investigate the clinical characteristics and treatment outcomes of a large population-based cohort of patients presenting with systemic non-cutaneous PTCL.